Ophthalmology

PANORAMA is the first prospective study of high-risk patients with non-proliferative diabetic retinopathy, but not DME, in the anti-VEGF era.

After analyzing information from a cohort of more than 380,000, investigators found an association between chronic illnesses and visual impairment.

Approximately half of all patients with diabetes suffer from keratopathy, yet diagnoses are still underwhelming. Annual screenings need to become more standard.

Jason Hsu, MD, and his colleagues at the Wills Eye Hospital presented a study at ARVO 2019 regarding short-term outcomes of patients, with nAMD, who switched from afliberecept to ranibizumab.

Mia Woodward, MD, discusses the future of telehealth in ophthalmology and the biggest issues that need to be corrected going forward.

Investigators examined more than 600 fellow eyes in a secondary analysis to identify 2 imaging features and 1 genetic variant linked to conversion.

In a 15-year study, investigators found that moderate consumption of eggs can significantly reduce a patient’s risk of developing incident, late-stage age related-macular degeneration

After a Mendelian analysis, investigators found that the genetic variants examined explained 4.4% of the variance in refractive error in their patient sample.

The humanized single-chain antibody fragment could become the first of its kind approved for the common eye condition.

One month after ripasudil treatment, investigators saw the mean foveal thickness decrease significantly and noted decreases in intraocular pressure.

Study finds that patients who received as-needed injections saw a significant anatomical and functional improvement.

Investigators found that intravitreal administration of aflibercept might alter the corneal endothelium within 6 months of their first injection.

Retrospective study assesses real-world outcomes of treating patients with chronic DME with Iluvien implant.

About 1000 people in the United States have RPE65 gene mutations and inherited retinal diseases.

The best way to diagnose diabetic macular edema is using optical coherence tomography, but it is costly.

The investigative solution improved patient metrics for itching, and could be considered for FDA submission later this year.

More than 80% of patients saw maintenance or improvement of BCVA, with a mean improvment of 7 letters or more, according to the ETDRS system.

Though it has been shown to not be harmful to patients at risk for the opitcal condition, calcium may still play a protective role in these patients.

Investigators from Johns Hopkins examined 16 RCTs to determine efficacy of three anti-VEGF agents for patients with neovascular age-related macular degeneration.

How soon could support vector machine learning be integrated into a retina specialist’s clinical practice?

FDA approved Rocklatan, a once-daily eye drop produced by Aerie Pharmaceuticals Inc., for patients with open-angle glaucoma or ocular hypertension.

While the diseases appear to be unrelated, there may be underlying factors that link them together.

There has been a debate about whether retina specialists under-treat with anti-VEGF therapy in the real-world setting.

Investigators found an association between disease progression change in done dark adaptation, yellow-blue, chromatic threshold and foveal thickness.

The loteprednol etabonate ophthalmic gel 0.38% was proven efficacious and safe in a pair of double-masked trials, and will reach the market by April 2019.